Thuy V Tran
Examiner (ID: 6857, Phone: (571)272-1828 , Office: P/2844 )
Most Active Art Unit | 2821 |
Art Unit(s) | 2821, 2844, 2856, 2814 |
Total Applications | 2202 |
Issued Applications | 1909 |
Pending Applications | 47 |
Abandoned Applications | 246 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18128838
[patent_doc_number] => 11555037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Purine diones as Wnt pathway modulators
[patent_app_type] => utility
[patent_app_number] => 17/100474
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 21631
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/100474 | Purine diones as Wnt pathway modulators | Nov 19, 2020 | Issued |
Array
(
[id] => 17156383
[patent_doc_number] => 20210317434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => SMALL-MOLECULE MEDIATED SIZE SELECTION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/953857
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16953857
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/953857 | Small-molecule mediated size selection of nucleic acids | Nov 19, 2020 | Issued |
Array
(
[id] => 18071413
[patent_doc_number] => 11530236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => CD73 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/083871
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27659
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083871
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083871 | CD73 inhibitors | Oct 28, 2020 | Issued |
Array
(
[id] => 16824222
[patent_doc_number] => 20210139515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => Preparation of Organosilicon Compound Having (Meth)acryloyloxy Group
[patent_app_type] => utility
[patent_app_number] => 17/077263
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077263
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077263 | Preparation of organosilicon compound having (meth)acryloyloxy group | Oct 21, 2020 | Issued |
Array
(
[id] => 16778443
[patent_doc_number] => 20210115521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => METHOD FOR INHIBITING TUMOR PROGRESSION OR DETERMINING TUMOR PROGRESSION STATE IN GASTRIC CANCER
[patent_app_type] => utility
[patent_app_number] => 17/074647
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17074647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/074647 | METHOD FOR INHIBITING TUMOR PROGRESSION OR DETERMINING TUMOR PROGRESSION STATE IN GASTRIC CANCER | Oct 19, 2020 | Abandoned |
Array
(
[id] => 17922807
[patent_doc_number] => 11466040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Methods of making metal halide perovskites
[patent_app_type] => utility
[patent_app_number] => 17/075280
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 27
[patent_no_of_words] => 9856
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075280
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075280 | Methods of making metal halide perovskites | Oct 19, 2020 | Issued |
Array
(
[id] => 16839373
[patent_doc_number] => 20210147385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => COMPOUNDS AND METHODS FOR TARGETING PATHOGENIC BLOOD VESSELS
[patent_app_type] => utility
[patent_app_number] => 17/072844
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072844
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/072844 | Compounds and methods for targeting pathogenic blood vessels | Oct 15, 2020 | Issued |
17/060602 | COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION | Sep 30, 2020 | Abandoned |
Array
(
[id] => 16710278
[patent_doc_number] => 20210077425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => AFFINITY MEDICANT CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 17/035529
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17035529
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/035529 | Affinity medicant conjugates | Sep 27, 2020 | Issued |
Array
(
[id] => 16570611
[patent_doc_number] => 20210009617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => COMPOSITIONS AND METHODS COMPRISING CONDUCTIVE METAL ORGANIC FRAMEWORKS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/032267
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/032267 | Compositions and methods comprising conductive metal organic frameworks and uses thereof | Sep 24, 2020 | Issued |
Array
(
[id] => 16570614
[patent_doc_number] => 20210009620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY
[patent_app_type] => utility
[patent_app_number] => 17/028109
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/028109 | PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY | Sep 21, 2020 | Abandoned |
Array
(
[id] => 17913169
[patent_doc_number] => 20220315564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/028720
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 149493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/028720 | Methods and compounds for restoring mutant p53 function | Sep 21, 2020 | Issued |
Array
(
[id] => 16555701
[patent_doc_number] => 20210000849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => SYNTHETIC COMPOSITION AND METHOD FOR MODULATING EMOTION AND MOOD DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/026616
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17026616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/026616 | Synthetic composition and method for modulating emotion and mood disorders | Sep 20, 2020 | Issued |
Array
(
[id] => 17571079
[patent_doc_number] => 11319337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => 3-desoxy derivative and pharmaceutical compositions thereof
[patent_app_type] => utility
[patent_app_number] => 17/025475
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10801
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025475
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/025475 | 3-desoxy derivative and pharmaceutical compositions thereof | Sep 17, 2020 | Issued |
Array
(
[id] => 16726575
[patent_doc_number] => 20210093722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => CYANOBACTERIUM EXTRACELLULAR POLYMER, COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/019991
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/019991 | Cyanobacterium extracellular polymer, compositions and uses thereof | Sep 13, 2020 | Issued |
Array
(
[id] => 16540815
[patent_doc_number] => 20200407228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => PREPARATION OF SI-H CONTAINING IODOSILANES VIA HALIDE EXCHANGE REACTION
[patent_app_type] => utility
[patent_app_number] => 17/017193
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/017193 | PREPARATION OF SI-H CONTAINING IODOSILANES VIA HALIDE EXCHANGE REACTION | Sep 9, 2020 | Pending |
Array
(
[id] => 16523646
[patent_doc_number] => 20200397726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => DISULFIRAM AND METAL SALT STAGGERED ORAL DOSING REGIMEN AND STAGGERED-RELEASE ORAL UNIT DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 17/013352
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013352
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/013352 | DISULFIRAM AND METAL SALT STAGGERED ORAL DOSING REGIMEN AND STAGGERED-RELEASE ORAL UNIT DOSAGE FORMS | Sep 3, 2020 | Abandoned |
Array
(
[id] => 16525214
[patent_doc_number] => 20200399294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => PROCESS FOR THE PRODUCTION OF ALKYLTIN HALIDES
[patent_app_type] => utility
[patent_app_number] => 17/012090
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012090 | PROCESS FOR THE PRODUCTION OF ALKYLTIN HALIDES | Sep 3, 2020 | Pending |
Array
(
[id] => 16512885
[patent_doc_number] => 20200392143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/006072
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 2123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006072
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/006072 | Heterocyclic compounds as LSD1 inhibitors | Aug 27, 2020 | Issued |
Array
(
[id] => 16656003
[patent_doc_number] => 20210052639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => COMPOSITIONS AND RELATED METHODS FOR THE ABLATION OF M2 MACROPHAGES AND MYELOID DERIVED SUPPRESSOR CELLS
[patent_app_type] => utility
[patent_app_number] => 16/997648
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997648
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997648 | COMPOSITIONS AND RELATED METHODS FOR THE ABLATION OF M2 MACROPHAGES AND MYELOID DERIVED SUPPRESSOR CELLS | Aug 18, 2020 | Pending |